Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8%
Other

Cheelcare Has a Record Month of Sales and Celebrates Milestone of 2,000 Companions Sold

By The Northwire Desk — AI Analysis Dec 08, 2025 · 07:01 CHER · 0.93 Cheelcare Inc.
CHER · Price

Executive Summary

  • Cheelcare announced the sale of its 2,000th Companion power‑assist device, marking a major commercial milestone.
  • The company recorded its strongest month ever for production and sales, indicating accelerating market adoption.
  • The announcement underscores growing demand for Cheelcare’s mobility solutions across North America.

Key Details

  • Milestone: 2,000 units of the Companion power‑assist device sold to date.
  • Recent Performance: Record month of production and sales (specific numbers not disclosed).
  • Product Description: The Companion is a compact, versatile power‑assist unit that attaches to manual wheelchairs, providing electric propulsion while preserving manual benefits.
  • Customer Impact Stories: Highlighted real‑world use cases from five customers demonstrating increased independence and functional mobility.
  • Funding Access: Devices are eligible for reimbursement through Ontario’s Assistive Devices Program (ADP), Quebec’s RAMQ, private insurers, and charitable organizations.
  • Future Outlook: Cheelcare is expanding its product portfolio, including the upcoming Curio robotic Complex Rehab wheelchair, and continues to supply OEM accessories to major manufacturers.

Notable Quotes

“Reaching 2,000 Companions sold—while also hitting our strongest sales month yet—shows just how deeply our product connects with our community.” – Eugene Cherny, CEO & Co‑Founder

“These aren’t just use cases—they’re deeply human experiences.” – Dima Paltsev, Co‑Founder

Read the original news release →

More from Cheelcare Inc.

Jun 18, 2026 · 07:31

Cheelcare Announces Upsizing of Non-Brokered Private Placement to $3.0 Million

Financings Jun 11, 2026 · 16:31

Small-cap mobility device maker scales commercialization but relies on recurring capital raises to fund cash burn.

Financings May 28, 2026 · 07:31

Cheelcare Secures Canadian IP Moat as Sales Momentum Builds Amidst Dilution Risks

M&A / Property May 11, 2026 · 07:31

Cheelcare extends its booking streak as Companion reimbursement catalyst takes hold, but the Curio regulatory journey and thin balance sheet keep risk elevated.

Production / Operations Apr 09, 2026 · 07:31

Cheelcare launches first Curio robotic wheelchair, turning R&D into revenue

Production / Operations Mar 25, 2026 · 07:31

Cheelcare Scales Revenue but Cash Burn Threatens Runway as Stock Fades from Peak

Earnings